The document announces an international conference on biowaivers and biosimilars to be held September 10-12, 2012 in San Antonio, Texas at the Hilton San Antonio Airport. The conference will discuss developments in biosimilar drug discovery, clinical trials, and regulatory and economic considerations. It is intended for professionals in pharmaceuticals, biotechnology, academia, and regulatory agencies working in areas related to biowaivers and biosimilars.

1. INTERNATIONAL CONFERENCE AND
EXHIBITION ON
BIOWAIVERS & BIOSIMILARS
SEPTEMBER 10-12, 2012
HILTON SAN ANTONIO AIRPORT
O
TEXAS, USA
Biosimilars have provided many challenges and opportunities in equal measure
for innovators and applicants. Biosimilars 2012 is designed to discuss the
Biosimilars-2012
development and progress of research in the areas of drug discovery, clinical
trials, regulatory and economic considerations towards Biosimilars and waiver
nomic
for Bioequivalence studies, BCS Biowaiver Studies, Dosage forms, Dissolution
Testing and IVIVC.
Biosimilars-2012 is a remarkable event which brings together a unique and
International mix of large and medium Pharm
Pharmaceutical, Biotech companies, leading
universities and Pharmacological and Biomedical research institutions making the
conference a perfect platform to share experience, foster collaborations across industry
share
and academia and evaluate emerging technologies across the globe.
Conference Highlights:
1. Biosimilars Pathways
2. EU mAb Guidelines
3. Skill Set for Biosimilars development
4. Biosimilars Therapeutics
5. Clinical Issues
6. Reference Standards
7. Guidelines for Marketing
8. Bioequivalence Testing
9. In vitro & In vivo Correlations
n
10. Biowaivers
11. Pharmaceutics
Important Dates:
Avail the early bird discounts and register on/before April 23, 2012.
Abstract Submission closes on: July 20, 2012
Registration closes on: July 29, 2012

2. We warmly invite you to attend and submit your abstract to International Conference
and Exhibition on Biowaivers and Biosimilars.
Biosimilars-2012 is comprised of 11 tracks and 63 sessions designed to offer
comprehensive sessions that address current issues related to Biowaivers and
Biosimilars.
Who should attend?
Legal Affairs, Principal Scientists, Chief Scientific Officers, Regulatory Affairs,
rincipal Regulatory
Healthcare Agencies, Pharmacovigilance, Directors, Deans, Professors and Associate
Professors from Universities, CEOs and Managers from follow
niversities, follow-on-Biologic, Health
Biologic, H
Economics, Bio-Pharmaceuticals, Drug safety and Risk M
armaceuticals, Management, Research and
,
Development and Commercial A Affairs, Ph.D Scholars and Researchers.
Venue: Hilton San Antonio Airport, USA
The Hilton San Antonio Airport hotel is conveniently located just 1.9 miles from San
Antonio International Airport (SAT). Across the highway from the celebrated North Star
Mall and the new Park North shopping & entertainment center which includes Laugh
Out Loud Comedy Club and Alamo Draft house Cinema. All of the major attractions of
San Antonio, Texas, including the world famous River Walk, the Alamo, SeaWorld, Six
Flags Fiesta Texas, and the San Antonio Zoo, are all minutes away. The Hilton San
Antonio, Texas Airport hotel is located close to a number of major corporations including
Xerox, Sprint, IBM, Southwest Business Corp., Washington Mutual, and Proctor &
Gamble, to name several.

3. Hilton San Antonio Airport
611 NW Loop 410,
San Antonio, Texas 78216,
USA
Tel: 1-210-340-6060
For more details, visit our website: http://www.omicsonline.org/biosimilars2012/
Email: biosimilars2012@omicsonline.org